Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Nanopore Technologies: Kate Priestman

Oxford Nanopore Technologies has appointed Kate Priestman as a non-executive director, effective July 13. Priestman most recently served as senior VP of R&D strategy, portfolio, and operations at GlaxoSmithKline. She currently also serves as a trustee of RBG Kew.